» Articles » PMID: 10528040

Behçet's Disease

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1999 Oct 21
PMID 10528040
Citations 517
Authors
Affiliations
Soon will be listed here.
Citing Articles

Musculoskeletal manifestations in a cohort of Behçet's disease patients and their impact on health-related quality of life.

Tharwat S, Jaber N, Aljubaeh H, Abumunshar O Intern Emerg Med. 2025; .

PMID: 40055302 DOI: 10.1007/s11739-025-03903-9.


Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol.

Geertsema-Hoeve B, van Laar J, Raaphorst J, Tas S, Welsing P, Goekoop R BMJ Open. 2025; 15(2):e089827.

PMID: 39915014 PMC: 11815459. DOI: 10.1136/bmjopen-2024-089827.


Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitus.

Mitsui E, Satomura A, Oikawa Y, Haisa A, Shimada A Diabetol Int. 2025; 16(1):188-193.

PMID: 39877436 PMC: 11769921. DOI: 10.1007/s13340-024-00776-9.


Clinical characteristics and quality of life of patients with Behcet's disease with arthritis in Japan.

Sugihara K, Wakiya R, Kameda T, Shimada H, Nakashima S, Miyagi T Sci Rep. 2024; 14(1):30416.

PMID: 39639150 PMC: 11621571. DOI: 10.1038/s41598-024-82102-6.


Clinical characteristics of coronary artery involvement in children with Behcet's syndrome.

Wang X, Zhang J, Wu J, Wang X, Yao X, Niu W Clin Rheumatol. 2024; 44(1):385-390.

PMID: 39585573 DOI: 10.1007/s10067-024-07228-4.